Niagen Bioscience, Inc. — Director's Dealing 2011

Oct 24, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2011-10-14

Reporting Person: Honig Barry C (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3298882	Direct
Common Stock	3395717	Indirect

Footnotes

F1: Reporting Person beneficially owns a total of 6,694,599 shares of Issuer's common stock (the "Shares"). Ownership includes (i) 3,298,882 Shares owned directly by the Reporting Person; (ii) 230,000 Shares owned by GRQ Consultants, Inc. Defined Benefits Plan for the benefit of the Reporting Person; (iii) 844,289 Shares owned by GRQ Consultants, Inc. 401K of which the Reporting Person is the beneficiary; and (iv) 2,321,428 Shares owned by GRQ Consultants Inc Roth 401K FBO Renee Honig, the Reporting Person's spouse, of which the Reporting Person has voting and investment power and disclaims beneficial ownership.